PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Insulin biphasic isophane (Sanofi Aventis)
Presentation Product Chemical substance Chapter Items dispensed
Insuman Comb 25 100units/ml inj 3ml pre-filled SoloStar pens
0601012D0BGAJBW
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System 2,018
Insuman Comb 50 100units/ml inj 3ml cartridges
0601012D0BGAFBU
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System 413
Insuman Comb 25 100units/ml inj 3ml cartridges
0601012D0BGABBN
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System 164
Insuman Comb 15 100units/ml inj 3ml cartridges
0601012D0BGADBS
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System 6
Insuman Comb 25 100units/ml inj 5ml vials
0601012D0BGAABM
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System 3
Insuman Comb 15 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAGBV
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 15 100units/ml inj 5ml vials
0601012D0BGACBR
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 25 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAHBW
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 50 100units/ml inj 3ml pre-filled OptiSet pens
0601012D0BGAIBX
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available
Insuman Comb 50 100units/ml inj 5ml vials
0601012D0BGAEBT
Insulin biphasic isophane (Sanofi Aventis) Biphasic isophane insulin Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.